Amar Greengrass Healthcare & Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 22-12-2024
- Paid Up Capital ₹ 1.75 M
as on 22-12-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.30 Cr
as on 22-12-2024
- Revenue 1473.81%
(FY 2021)
- Profit -64.20%
(FY 2021)
- Ebitda -64.20%
(FY 2021)
- Net Worth 47.88%
(FY 2021)
- Total Assets 38.59%
(FY 2021)
About Amar Greengrass Healthcare & Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.75 M.
The company currently has active open charges totaling ₹2.30 Cr.
Prabhakar Kumar and Nivedita serve as directors at the Company.
- CIN/LLPIN
U15100DL2016PTC304554
- Company No.
304554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Amar Greengrass Healthcare & Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhakar Kumar  | Director | 17-Aug-2016 | Current |
| Nivedita | Director | 17-Aug-2016 | Current |
Financial Performance of Amar Greengrass Healthcare & Diagnostics.
Amar Greengrass Healthcare & Diagnostics Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1473.81% increase. The company also saw a substantial fall in profitability, with a 64.2% decrease in profit. The company's net worth Soared by an impressive increase of 47.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amar Greengrass Healthcare & Diagnostics?
In 2021, Amar Greengrass Healthcare & Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aghd Pharmaceutical Private LimitedActive 3 years 3 monthsPrabhakar Kumar and Nivedita are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 10 May 2023 | ₹2.30 Cr | Open |
How Many Employees Work at Amar Greengrass Healthcare & Diagnostics?
Unlock and access historical data on people associated with Amar Greengrass Healthcare & Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amar Greengrass Healthcare & Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amar Greengrass Healthcare & Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
